A National Study of the Impact of Initial Debridement Timing on Outcomes for Patients with Deep Sternal Wound Infection

作者:Wu Lizi; Chung Kevin C; Waljee Jennifer F; Momoh Adeyiza O; Zhong Lin; Sears Erika D*
来源:Plastic and Reconstructive Surgery, 2016, 137(2): 414E-423E.
DOI:10.1097/01.prs.0000475785.14328.b2

摘要

Background: Excisional debridement for patients with deep sternal wound infection is a main component of treatment. This study aims to evaluate the impact of delayed excisional debridement on mortality and associated outcomes. Methods: The authors analyzed the MarketScan database from 2009 to 2013 to identify patients with deep sternal wound infection who received surgical intervention. A logistic regression model was created to model mortality. Poisson regression models were used to model number of procedures, number of hospitalizations, and length of stay. A log-linear regression model was used for cost analysis. All analyses were adjusted for patient risk factors. Results: The final cohort included 1335 patients with 12 percent in-hospital mortality. There was considerable variation in timing of debridement among patients with deep sternal wound infection, with more than 25 percent undergoing initial debridement 4 or more days after diagnosis, and 10 percent undergoing debridement more than 1 week after diagnosis. Patients undergoing delayed debridement had progressively higher risk for greater number of admissions and total hospital days compared with those undergoing early debridement. Patients undergoing debridement on the day of diagnosis of deep sternal wound infection had a predicted 34 total hospital days, compared with 49 total hospital days for patients undergoing debridement more than 7 days after diagnosis. Conclusions: Patients treated with early surgical intervention had fewer hospital admissions and fewer hospital days than patients undergoing delayed surgical treatment. Protocols to facilitate early debridement have the potential to improve quality and efficiency of deep sternal wound infection care. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

  • 出版日期2016-2